相似化合物
1638761-59-7 142253-55-2 142253-56-3欧盟法规
ECHA物质C&L通报上下游产品
3-hydroxymethyl-azetidine-1-carboxylic acid tert-butyl ester tert-butyl dicarbonatedi-tert-butyl dicarbonate 1-(t-butyloxycarbonyl)-azetidine-3-carboxylic acid carbon monoxide 3-((E)-2-ethoxycarbonylvinyl)azetidine-1-carboxylic acid tert-butyl ester 3-((E)-2-carboxyvinyl)azetidine-1-carboxylic acid tert-butyl ester 3-((E)-2-(methyl((1R)-1-(methyl((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)carbamoyl)vinyl)azetidine-1-carboxylic acid tert-butyl ester 3-[4-(3-acetylaminophenyl)piperidin-1-ylmethyl]azetidine-1-carboxylic acid tert-butyl ester 合成工艺路线路线简述
- 合成目标产物 3-Formyl-Azetidine-1-Carboxylic Acid Tert-Butyl Ester 主要起始原料 1-Boc-Azetidine-3-Yl-Methanol
- 1248510-38-4 = 177947-96-5 + 852324-38-0
反应条件:1.1 Reagents: Hydrogen Catalysts: Dicarbonylrhodium Acetylacetonate,2,2′,2′′,2′′′-[1,2-Phenylenebis[(1S,3S)-Tetrahydro-5,8-Dioxo-1H-[1,2,4]Diazaphos... Solvents: Toluene; 140 Psi,35 °C; 12 H,Cooled
标题:Enantioselective Hydroformylation Of N-Vinyl Carboxamides,Allyl Carbamates,And Allyl Ethers Using Chiral Diazaphospholane Ligands
作者:Mcdonald,Richard I.; Wong,Gene W.; Neupane,Ram P.; Stahl,Shannon S.; Landis,Clark R.
参考文献:Journal Of The American Chemical Society 日期:2010 卷标:132(40) 页码:14027-14029
3-羟甲基氮杂环丁烷-1-羧酸叔丁酯置于草酰氯,三乙胺体系中,用 二氯甲烷,二甲基亚砜 用作溶剂,以65 %的收率获得3-甲酰基氮杂环丁烷-1-羧酸叔丁酯
参考文献:氟化脂肪二氮杂环丙烷:制备,表征和模型光标记研究
标题:氟化脂肪二氮杂环丙烷:制备,表征和模型光标记研究
摘要:合成并表征了以前未知的二氟甲基二氮杂环丙烷和以前被忽视的三氟甲基-脂肪族二氮杂环丙烷.模型光标记实验和生物学研究表明,这些化合物确实可以用作光亲和标记.
Doi:10.1021/acs.Joc.2C02262
海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2912110000-甲醛
2912120000-乙醛 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-10226449-B2
优先权日:2013-12-20
标 题:Heterocyclic modulators of lipid synthesis and combinations thereof
发明人:HEUER TIMOTHY SEAN; OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; DUKE GREGORY; OHOL-GUPTA YAMINI; O'FARRELL MARIE
权利人:3 V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.
专利号:US-9428502-B2
优先权日:2012-07-03
标题:Heterocyclic modulators of lipid synthesis
发明人:OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; WAGMAN ALLAN S
权利人:3-V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.
专利号:US-9708336-B2
优先权日:2014-01-22
标题 :Metallo-beta-lactamase inhibitors
发明人:MANDAL MIHIR; TANG HAIFENG; XIAO LI; SU JING; LI GUOQING; YANG SHU-WEI; PAN WEIDONG; TANG HAIQUN; DEJESUS REYNALDA; HICKS JACQUELINE; LOMBARDO MATTHEW; CHU HONG; HAGMANN WILLIAM; PASTERNAK ALEX; GU XIN; JIANG JINLONG; DONG SHUZHI; DING FA-XIANG; LONDON CLARE; BISWAS DIPSHIKHA; YOUNG KATHERINE; HUNTER DAVID N; ZHAO ZHIQIANG; YANG DEXI
权利人:MERCK SHARP & DOHME
摘要:The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.
专利号:US-2013060019-A1
优先权日:2011-09-07
标 题 :Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto
发明人:BRONK BRIAN SCOTT; AUSTIN WESLEY FRANCIS; CREASER STEFFEN PHILLIP; FULLER NATHAN OLIVER; HUBBS JED LEE; SHEN RUICHAO
权利人:BRONK BRIAN SCOTT; AUSTIN WESLEY FRANCIS; CREASER STEFFEN PHILLIP; FULLER NATHAN OLIVER; HUBBS JED LEE; SHEN RUICHAO; SATORI PHARMACEUTICALS INC
摘要:The present invention provides methods of making a compound of formula II: n n n n n n n n n n or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , and L are as defined and described herein.
专利号:US-2018222892-A1
优先权日:2012-07-03
标 题 :Heterocyclic modulators of lipid synthesis
专利号:EP-3083583-B1
优先权日:2013-12-20
标 题:Heterocyclic modulators of lipid synthesis and combinations thereof